Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
link
Tags
fda
medicine
science
archive
coronavirus
covid-19
europe
extreme
health
medical
tc
health care industry
author_name|malak saleh
balderton capital
biotech
boehringer ingelheim
cannabis
clinical trials
crowdfunding
disease & medical conditions
eli lilly
empagliflozin
engineering
europe blog main
europe top stories
fundings & exits
government
indiana blog main
indiana top stories
jpl
language|en-us
life sciences
marijuana
medical marijuana
mytomorrows
nasa
national blog main
new york blog main
new york top stories
news
What
approval
11
×
patients
11
×
fda
treatment
called
gets
announced
based
device
drug
epilepsy
low
medical
regulatory
adults
approved
cannabis
cbd
coronavirus
covid
developed
hospitals
medicine
nasa
release
severe
startup
use
used
ventilator
access
accessibility
adult
age
alive
allowing
amid
approves
authorization
beginning
Language
unset
Current search:
approval
×
patients
×
@engadget.com
3 months ago
Vibrating belt that treats low bone density gets FDA approval
@wired.com
4 months ago
The Age of Crispr Medicine Is Here
@slashgear.com
3 years ago
Injectable extended-release HIV regimen gets milestone FDA approval
@slashgear.com
3 years ago
FDA approves Inmazeb, the first Ebola treatment for children and adults
@extremetech.com
3 years ago
NASA’s Coronavirus Ventilator Gets FDA Approval
@extremetech.com
4 years ago
MIT Develops Cheap, Open Source Ventilator for Coronavirus Treatment
@xconomy.com
4 years ago
FDA Rejects Boehringer Ingelheim, Eli Lilly Drug for Type 1 Diabetes
@techcrunch.com
5 years ago
With CBD, marijuana-based medicine gets its first greenlight from the FDA
@WIRED
6 years ago
Currently, CBD is a Schedule 1 drug like cannabis, and the DEA must reschedule it before the epilepsy medication can be sold. If approved, this would have ...
@androidauthority.com
6 years ago
Smart wearable Embrace is now an FDA-approved medical device for epilepsy patients
@techcrunch.com
9 years ago
Amid ‘Right To Try’ Debate, myTomorrows Raises €4.5M To Give Patients Access To Development-Stage Drugs